Skip to main content
. 2023 Feb 7;17(2):39–57. doi: 10.1049/syb2.12058

TABLE 5.

The association analysis between risk scores and relapse‐free survival in early‐stage PDAC.

Groups Relapse‐free survival
Patients (n = 93) MST Events HR (95% CI) p*
Risk scores
Lower 47 14 872 Reference 0.007
Higher 46 21 493 2.90 (1.33–6.15)

Note: *adjusted by neoplasm histological grade and residual resection.

Abbreviations: CI, confidence interval; HR, hazard ratio; MST, median survival time; PDAC, pancreatic ductal adenocarcinoma; TCGA, The Cancer Genome Atlas.